|
BIOSENSE WEBSTER INC QDOT MICRO; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
|
Back to Search Results |
|
| Catalog Number |
D139504 |
| Medical Device Problem Code |
Patient Device Interaction Problem (4001)
|
| Health Effect - Clinical Code |
Cardiac Tamponade (2226)
|
| Date of Event |
11/11/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Device investigation details: an analysis of the product could not be performed since a physical sample was not received for evaluation.An evaluation of the manufacturing record could not be performed as the required product identification number was not provided to complete the evaluation.However, if the product or product id numbers are received at a later date, the investigation will be updated as applicable.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.Note: although the physician¿s opinion on the cause of this adverse event that it was the right ventricle perforation from the rv catheter with pacing and on isuprel, ablation did take place.As such, the event is being reported under the qdot ablation catheter.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's ref.#: (b)(4).
|
| |
|
Event or Problem Description
|
|
After an accessory pathway ablation procedure with a qdot catheter and the patient experienced pericardial effusion treated with pericardiocentesis.It was reported that at the conclusion of an accessory pathway procedure, a pericardial effusion was noticed in the patient.While checking for an effusion in the patient post-procedure, a pericardial effusion was noticed and confirmed on intracardiac echocardiography (ice).The medical intervention provided to the patient was pericardiocentesis, and about 800ml of fluid was removed from the patient.They also utilized 2d echo in order to confirm the pericardial effusion, as well as for the pericardiocentesis.The patient is in stable condition at this time.The physician believes the webster quadrapolar catheter being utilized in the right ventricle (rv), could have caused the issue.The physician¿s opinion on the cause of this adverse event was right ventricle perforation from the rv catheter with pacing and on isuprel.The energy source used when the adverse event occurred was radiofrequency (rf).The sheath and the catheters only went to the left atrium (la) with ablation catheter; there was no exchange.One transseptal puncture site was performed during the procedure.No ablations were performed within the pulmonary veins.Prior to noting the pericardial effusion, ablation had already been performed.No evidence of steam pop.The flow setting was 2ml.The patient did not require cardiac surgery.The correct catheter settings were selected on the generator.No issues with flow rate change at the start of ablation.No force visualization features were used.The visitag module parameters for stability used were 3mm, 3 sec, 3gm for 25%, and 3mm.The additional filter used with the visitag was impedance.The color option used prospectively was impedance drop.
|
| |
|
Search Alerts/Recalls
|
|
|